Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-30 16:28:59 - browse：658

From 2017 to 2020, Stimwave implanted nearly 8,000 patients with nerve stimulators containing dummy pieces of plastic. Adobe

The Securities and Exchange Commission on Tuesday charged the former CEO of Stimwave, a company that sold devices containing dummy pieces of plastic, with defrauding investors out of $41 million.

Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019, when the fraud came to light. Under her leadership, Stimwave warped the design of the device to better align with insurance codes, resulting in unnecessary plastic components that allowed the company to sell their products for thousands of dollars more than they otherwise could. From 2017 to 2020, the company implanted nearly 8,000 patients with these devices.

STAT published new details about the Stimwave story in May, learning from former employees that Perryman broke into Stimwave’s Florida headquarters to steal back devices after her termination in 2019. The fraud laid bare the limits of the Food and Drug Administration’s device surveillance system, doctors’ ability to scrutinize device effectiveness, and how impossible it is for patients to get answers about the implants they receive.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Elisabeth Bik tackles the widespread issue of research misconduct

leisure time

WSS

Primary care doctor shortage won't be solved by free med school tuition

Empower primary care with adequate payments and technology

Empower primary care with adequate payments and technology

The creative science of coining drug names

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

HHS's proposed rule does nothing to address the climate crisis

entertainment

Wikipedia

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

Medicare Advantage isn’t working — for anyone

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Elisabeth Bik tackles the widespread issue of research misconduct

Tori Bowie and the unacceptable rates of Black maternal death

Children’s Hospital revives plan for pedestrian bridge

Trump demands the U.S. pay no more for drugs than other countries … again

Change Healthcare cyberattack shows risk of industry consolidation

Affirmative action in medical school literally saved lives

Children’s Hospital revives plan for pedestrian bridge

focus

Class action alleges UnitedHealth concealed DOJ probe

The creative science of coining drug names

Has Bernie Sanders reached the limit of his pharma bullying effort?

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

The creative science of coining drug names

Childhood vaccination ad campaign launches in the U.K.

knowledge

focus

leisure time

leisure time